Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.6.1 (sulfatase)
 3,205 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Latencies and phosphomannosyl-enzyme receptors of lysosomal enzymes were studied in the skeletal muscles of NMRI mice during the appearance (0-1 days) and the repair (3-9 days) of muscle fiber injuries after a single bout of prolonged running (9 hr, 13.5 m/min). The unsedimentable, releasable, and bound activities of arylsulfatase, beta-N-acetylglucosaminidase, beta-D-glucuronidase, cathepsin C, and ribonuclease as well as the content and occupancy of phosphomannosyl-enzyme receptors of lysosomal enzymes were assayed. The distribution of enzyme activities in different fractions as well as the changes after exertion greatly varied between different lysosomal enzymes. In general, the total activities and also the distribution of enzyme activities in different fractions were unaffected 1 hr after exertion, but on the day after exertion small increases were observed in the free and releasable activities. The highest enzyme activities both in the homogenate and in different fractions were recorded 3 days after exertion, after which the activities slowly decreased. The increases of enzyme activities were higher in the free and releasable fractions than in the homogenate but the changes in the proportional distributions of lysosomal enzyme activities between different fractions were minor. The present study also showed the presence of phosphomannosyl-enzyme receptors of lysosomal enzymes in the membranes of skeletal muscles. The total content of phosphomannosyl-enzyme receptors was unchanged 0-3 days after exertion but a small increase occurred 5-8 days after exertion. Instead, the occupancy of these lysosomal receptors with endogenous enzymes was significantly increased 1-5 days after exertion and decreased later to the control level.
 ...
PMID:Latencies and phosphomannosyl-enzyme receptors of lysosomal enzymes during the appearance and repair of exercise injuries in mouse skeletal muscles. 609 63

We have examined the effect of chloroquine on rat liver lysosomal enzyme distributions after isopycnic centrifugation in a sucrose gradient. Chloroquine injection causes the large majority of cathepsin C, acid phosphatase and N acetyl glucosaminidase to migrate towards lower density regions; on the other hand only about 50% of arylsulfatase and acid deoxyribonuclease are subjected to such a density shift. To specifically mark hepatocyte lysosomes and sinusoidal cell lysosomes, rats were injected with galactosylated bovine serum albumin (A) or mannosylated bovine serum albumin (B) labelled with 125I tyramine cellobiose; A is selectively endocytosed by hepatocytes, B by sinusoidal cells. The radioactivity distribution is affected by chloroquine in the same way as cathepsin C, after injection of A though it is not influenced by chloroquine after the injection of B. These results show that chloroquine does not modify the density of liver sinusoidal cell lysosomes when it decreases the density of hepatocyte lysosomes. Such a difference could result from the fact that sinusoidal cell lysosomes do not accumulate chloroquine to the same extent as hepatocyte lysosomes. Chloroquine treatment could be useful to distinguish between hepatocyte lysosomes and sinusoidal cell lysosomes.
 ...
PMID:Chloroquine allows to distinguish between hepatocyte lysosomes and sinusoidal cell lysosomes. 843 31

Myosteatosis, the infiltration of fat in skeletal muscle, is associated with lower skeletal muscle density (SMD) as detected by computed tomography (CT). It increases with aging and obesity and is thought to play a role in the aetiology of insulin resistance and type II diabetes. The clinical significance of myosteatosis in cancer cachexia, however, remains to be determined. Along with demonstrable subcutaneous and visceral lipolysis, myosteatosis may also be a key component of the syndrome. We aimed to investigate the use of human urine as a non-invasive way to screen for molecular biomarkers of myosteatosis/reduced SMD using SELDI-TOF mass spectrometry. Pre-operative CT scans of patients undergoing surgery for upper gastrointestinal or hepatopancreaticobiliary cancer were analysed at the level of the third lumbar vertebrae. Myosteatosis was inferred as the presence of reduced SMD, which was defined as Hounsfield units for skeletal muscle <39.5 (two standard deviations below a normal healthy cohort). Urine was analysed by mass spectrometry using CM10 and IMAC30 SELDI-chips. Peaks observed in the CM10 and IMAC30 chip types, showed marked expressional differences between control and myosteatosis, were further investigated by mascot SELDI matrix matching. A total of 55 patients was recruited; 31 patients were found to be myosteatotic on CT scan. Application of the IMAC30-derived model to the entire cohort showed a sensitivity of 97%, specificity of 71% and an overall correctness of 85%. Application of the CM10 chipset-based model to the entire cohort, showed a 77% sensitivity, 67% specificity and 73% overall correctness. Analysis of the peaks of interest resulted in the identification of significant fragments of cathepsin C, argin, arylsulfatase A and glial fibrillary acidic protein. We identified several potential urinary molecular biomarkers associated with reduced SMD in cancer. Such markers are potentially useful in deriving a clinical screening test for myosteatosis.
 ...
PMID:Proteomic identification of potential markers of myosteatosis in human urine. 2990 12